Quarry LP Buys 123 Shares of The Clorox Company (NYSE:CLX)

Quarry LP grew its stake in shares of The Clorox Company (NYSE:CLX) by 53.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 352 shares of the company’s stock after buying an additional 123 shares during the quarter. Quarry LP’s holdings in Clorox were worth $57,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Mizuho Securities USA LLC grew its position in Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the last quarter. Van ECK Associates Corp boosted its stake in shares of Clorox by 1,715.5% during the second quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after purchasing an additional 1,380,724 shares in the last quarter. Nuance Investments LLC grew its holdings in shares of Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares during the last quarter. Ilex Capital Partners UK LLP increased its stake in shares of Clorox by 512.7% in the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after buying an additional 453,624 shares during the period. Finally, Wulff Hansen & CO. raised its holdings in Clorox by 13,547.0% in the 2nd quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock valued at $60,063,000 after buying an additional 436,891 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

NYSE:CLX opened at $167.42 on Tuesday. The firm has a market capitalization of $20.72 billion, a P/E ratio of 58.33, a P/E/G ratio of 3.08 and a beta of 0.42. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a fifty day moving average of $163.59 and a 200-day moving average of $150.86. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.49 earnings per share. As a group, sell-side analysts anticipate that The Clorox Company will post 6.85 EPS for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 2.91%. Clorox’s payout ratio is currently 170.04%.

Analysts Set New Price Targets

Several equities analysts have issued reports on CLX shares. JPMorgan Chase & Co. upped their price target on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research report on Friday, October 11th. Evercore ISI lowered their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Citigroup raised their price objective on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, DA Davidson upped their target price on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.